Synthaverse (WAR:SVE) ROCE %: -1.60% (As of Mar. 2026)


WAR:SVE Synthaverse SA WAR:SVE
55 GF Score
Price zł2.66
GF Value zł3.04
Valuation Modestly Undervalued
! 8 Warning Signs
View Full Analysis

What is Synthaverse ROCE %?

Synthaverse WAR:SVE -1.67% 55 ROCE % is -1.60% as of Mar. 2026. GuruFocus rates WAR:SVE with a GF Score™ of 55/100 and a GF Value™ of zł3.04 (Modestly Undervalued). The stock has 8 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Synthaverse's annualized ROCE % for the quarter that ended in Mar. 2026 was -1.60%.

Synthaverse  (WAR:SVE) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Synthaverse ROCE % Related Terms

Synthaverse ROCE % Historical Data

* Premium members only.

The historical data trend for Synthaverse's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Synthaverse ROCE % Chart

Synthaverse Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.92 8.36 4.89 5.20 -9.09

Synthaverse Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.55 -8.29 -11.48 -13.31 -1.60
WAR:SVE
55GF Score
Synthaverse SA WAR:SVE
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Synthaverse ROCE % Calculation

Synthaverse's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-19.301/( ( (298.622 - 42.97) + (304.131 - 134.961) )/ 2 )
=-19.301/( (255.652+169.17)/ 2 )
=-19.301/212.411
=-9.09 %

Synthaverse's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-2.664/( ( (304.131 - 134.961) + (297.735 - 133.653) )/ 2 )
=-2.664/( ( 169.17 + 164.082 )/ 2 )
=-2.664/166.626
=-1.60 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -1.60% mean?
Synthaverse (WAR:SVE) has a ROCE % of -1.60% as of Mar. 2026.
Is Synthaverse's ROCE % too high?
Synthaverse's current ROCE % is -1.60%. Overall, Synthaverse has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Synthaverse's ROCE % compare to VRTX and REGN?
Synthaverse's ROCE % of -1.60% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Synthaverse's current ROCE % is -1.60%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Synthaverse stock overvalued right now?
Based on GuruFocus' analysis, Synthaverse (WAR:SVE) is currently considered Modestly Undervalued. The stock's GF Value™ is zł3.04, compared to a current price of zł2.66 — trading 12.7% below its estimated fair value. The current ROCE % is -1.60%. Synthaverse's overall GF Score™ is 55/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Synthaverse (WAR:SVE), the current ROCE % is -1.60% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Synthaverse (WAR:SVE) Overvalued in 2026?

Based on GuruFocus' analysis, Synthaverse stock appears to be undervalued. The current stock price of zł2.66 is trading 12.7% below its estimated GF Value™ of zł3.04. GuruFocus considers Synthaverse to be Modestly Undervalued.

Key valuation signals for WAR:SVE:

  • ROCE %: -1.60%
  • GF Value™: zł3.04 vs. price of zł2.66 (12.7% below fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the WAR:SVE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Synthaverse Business Description

Other Exchanges 6NQ:Germany
Address 10, Uniwersytecka street, Lublin, POL, 20-029
Synthaverse SA is a global pharmaceutical company. Its goal is to provide the best, innovative and unique solutions for medicine. Its work is based on scientific and health knowledge. Along with its expert approach, it allows the company to create reliable and unique products. It manufactures one of the few drugs used internationally in the oncological immunotherapy of bladder cancer.
55GF Score

Get the complete analysis for WAR:SVE

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł2.66
Price
zł3.04
GF Value